The current valuation score of Catalyst Pharmaceuticals Inc is 7.03, ranking 141 out of 156 in the Pharmaceuticals industry. Its current P/E ratio is 17.43, which is 110.67% below the recent high of 36.72 and 39.04% above the recent low of 10.62.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.